Skip to main content
Loading...

News and Events

Find out all about our latest news and also what industry events we will be attending in the coming months via the links below.

Latest News

  • CARBOGEN AMCIS Announces Two Successful FDA Inspections at Its Manufacturing Sites in Neuland and Aarau, Switzerland

    BUBENDORF, Switzerland (July 22, 2024) —Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of U.S. Food and Drug Administration (FDA) inspections at its Neuland and Aarau sites.
    24 July 2024
  • CARBOGEN AMCIS announces successful ANVISA audit of its facility in China

    BUBENDORF, Switzerland (19 March 2024) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai.
    19 March 2024
  • CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing performance

    Manchester, UK (20 June 2023) – CARBOGEN AMCIS Manchester, a member of the Switzerland-based CARBOGEN AMCIS Group, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, won the Manufacturing and Resource Efficiency Award at the prestigious Chemistry Industry Awards last week.
    20 June 2023
  • CARBOGEN AMCIS announces successful FDA and Swissmedic inspections of its facilities in Switzerland

    BUBENDORF, Switzerland (02 June 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the completion of a U.S. Food and Drug Administration (FDA) inspection at its headquarters in Bubendorf, Switzerland and a Swissmedic routine inspection at Bubendorf, Aarau and Neuland, Switzerland.
    02 June 2023
  • CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France

    Bubendorf, Switzerland (3 February 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has opened a state-of-the-art facility in Saint-Beauzire, France.
    03 February 2023
  • CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland

    29 September 2022
  • CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

    BUBENDORF, Switzerland (October 11th, 2017) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today that its Bubendorf, Switzerland API manufacturing site has successfully completed a routine U.S. Food and Drug Administration (FDA) inspection.
  • CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

    BUBENDORF, Switzerland (July 21st, 2017) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced the renewal of cGMP certificates, and the successful completion of Swissmedic inspections at three of its sites.
  • Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS

    AHMEDABAD, INDIA, August 11, 2016 – Dishman Pharmaceuticals and Chemicals Ltd (DPCL), leading outsourcing partner for the global pharmaceutical industry, today marked the 10-year anniversary of its acquisition of CARBOGEN AMCIS. A significant milestone of growth and development of Indian-Swiss business relations.
  • CARBOGEN AMCIS Sites at Aarau and Neuland in Switzerland Successfully Pass FDA Inspection

    BUBENDORF, Switzerland (July 13th, 2016) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced, after reception of the Establishment Inspection Report (EIR), that two of its Swiss sites have successfully completed a U.S. Food and Drug Administration (FDA) inspection.

    Upcoming Events

    Search

    BIO Asia Taiwan

    Taipei Nangang Exhibition Center, Hall 1
    L723
     25/07/2024 to 28/07/2024

    ChemOutsourcing

    Parsippany Hilton, Parsippany, NJ
    Booth 14
     04/09/2024 to 06/09/2024

    CPhI Worldwide Milan 2024

    Fiera Milano, Italy
    7A114
     08/10/2024 to 10/10/2024

    Bio Japan 2024

    PACIFICO Yokohama, Yokohama, Kanagawa, Japan
    SWISS Pavilion
     09/10/2024 to 11/10/2024

    AAPS PharmSci 360

    Salt Palace Convention Center, Salt Lake City, UT
    Booth #2445
     21/10/2024 to 23/10/2024

    BIO-Europe

    Stockholm, Sweden
    Booth #182
     04/11/2024 to 06/11/2024

    Together 2024

    Basel Messe, Switzerland
     06/11/2024 to 06/11/2024

    Chemtogether 2024

    ETH Hönggerberg, Switzerland
     13/11/2024 to 13/11/2024

    BOS Manchester

    Manchester Central
    Booth #22
     26/11/2024 to 27/11/2024

    BioFit 2024

    Lille, France
     03/12/2024 to 04/12/2024

      Access Our Media Kit

      About Us

      Logo & Media Library